Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Expansion ⢠Strong Cash Flow ⢠High Leverage CNO shows stronger margins and cash generation, but elevated leverage, thin equity, low asset returns, and richer valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Range-bound trading ⢠Fading momentum ⢠Breakout needed Support Level: $54.20â$54.50 Resistance Level: $55.30â$55.40 CNO was broadly flat over the last month, holding above $54.20â$54.50 support but needing a decisive break above $55.30â$55.40 resistance to revive upside toward $56.75.
Sentiment & News
Key News Insights: ⢠Medicare Expansion ⢠Agent Footprint ⢠Mixed Institutions CNO is pursuing worksite and Medicare expansion amid mixed but notable institutional interest, supporting a cautiously positive growth outlook.
AI Summary
CNO's investment case has shifted to scalable agent productivity, worksite/Medicare distribution, and fee-based asset gathering, but at ~18x earnings and 2x book investors should require sustained margin gains and capital returns before adding exposure. Watch for a breakout above $55.40 as confirmation, while elevated leverage and rate-sensitive investment assets make a break below $54.20 a meaningful risk signal.
Description
CNO Financial Group, through its subsidiaries, underwrites and administers a range of life, health and annuity products for middle-income and senior customers in the United States, including Medicare-related coverage, supplemental health and long-term care offerings. The company distributes its products via agents, independent producers, direct channels and worksite/group relationships, and markets under the Bankers Life, Washington National and Colonial Penn brands. Founded in 1979, CNO is headquartered in Carmel, Indiana.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jul 31 | Aug 7 | CNO | CNO Financial Group, Inc. | Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation. | Closed | +0.1% |